EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Remimazolam: a comprehensive review

Aleksander Aszkiełowicz, Cezary Kapłan, Patrycja Kapica, Rozalia Marszałek

Anaesthesiology Intensive Therapy · 01.10.2025 · 57 (1) · 257-266

DOI: 10.5114/ait/210611 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anaesthesiology Intensive Therapy, online erschienen am 01.10.2025. Verfasst von Aleksander Aszkiełowicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Benzodiazepines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remimazolam is a novel, ultra-short-acting benzodiazepine that has emerged as a promising agent in modern anesthetic and intensive care practice. This review pre­sents a detailed analysis of its pharmacokinetic and pharmacodynamic properties, clinical efficacy, and safety profile across various patient populations and procedural contexts. The drug’s rapid metabolism by plasma esterases, minimal reliance on hepatic or renal function, and availability of a reversal agent (flumazenil) distinguish it from traditional sedatives such as propofol and midazolam. Clinical data support its utility in procedural sedation, general anesthesia, and ICU sedation, particularly in elderly and hemodynamically unstable patients. Pediatric applications are discussed, highlighting the early evidence and dosing considerations. The review also compares remimazolam with other agents such as propofol and dexmedetomidine, underlining its advantages in cardiovascular stability and recovery profiles. While current results are encouraging, the article emphasizes the need for further research to establish standardized protocols and explore its long-term safety, especially in vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypnotics and SedativesBenzodiazepinesHumansCritical Care

Stichwörter der Autor:innen

ICU sedationelderly patientsintravenous anesthesiapediatric anesthesiapharmacokineticsprocedural sedationremimazolam

Substanzen

remimazolamHypnotics and SedativesBenzodiazepines

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Zitieren

APA

Aszkiełowicz, A., Kapłan, C., Kapica, P., & Marszałek, R. (2025). Remimazolam: a comprehensive review. Anaesthesiology Intensive Therapy, 57(1), 257-266. https://doi.org/10.5114/ait/210611

Vancouver

Aszkiełowicz A, Kapłan C, Kapica P, Marszałek R. Remimazolam: a comprehensive review. Anaesthesiology Intensive Therapy. 2025;57(1):257-266. doi:10.5114/ait/210611

BibTeX
@article{Aszkieowicz2025,
  author = {Aszkiełowicz, Aleksander and Kapłan, Cezary and Kapica, Patrycja and Marszałek, Rozalia},
  title = {Remimazolam: a comprehensive review},
  journal = {Anaesthesiology Intensive Therapy},
  year = {2025},
  volume = {57},
  number = {1},
  pages = {257--266},
  doi = {10.5114/ait/210611}
}
Kostenlos starten →